1.
Madabhavi I, KS S, Sarkar M, Modi M. Exceptional Responder to Immunotherapy: A Rare Case of Post- HSCT DLBCL Relapse Responding to Nivolumab. Int J Hematol Oncol Stem Cell Res. 2019;13(2):68-71.